Organon & Co. Common Stock (OGN)

R&D Expense Growth

-3.23%

Quarterly · Period ending:

OGN logo

OGN R&D Expense Growth

Latest reported-3.23%
OGN Quarterly R&D Growth (QoQ) (0.00% → -3.23%)
High-resolution chart · PNG

OGN r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Organon & Co. Common Stock R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-3.2258%
2.1978%
8.3333%
-11.5789%
-1.0417%
-26.1538%
17.1171%
-4.3103%
3.5714%
-16.4179%
-2.1898%
7.0313%
-0.7752%
-9.1549%
11.811%
19.8113%
10.4167%
-12.7273%
-0.9009%
46.0526%
13.4328%
11.6667%
11.1111%
5.8824%
13.3333%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.